0
Startups & Venture·September 21, 2026·1 min read

Altis Labs, whose AI model analyzes CT scans taken during oncology trials and produces predictions tied to patient survival, has raised a $25M Series A

Share

AI that reads CT scans for oncology trials is a wedge into how endpoints are defined and drugs are advanced. If you run clinical or R&D orgs, assume regulators and partners will start asking why you’re not using similar tools to de-risk trials and stratify patients earlier.

Startups & Venture

Aided by AI, young people in China launched 7M+ one-person startups in 2025 to escape a bleak job market, up ~42% from 2024, as they face fierce competition

A 42% jump to 7M+ solo AI businesses in a year is a labor-structure story — AI is turning unemployment into hyper-fragmented micro-entrepreneurship. For operators, this is both a demand pool and a competitor set: expect more niche tools, services, and content from one-person shops, and more pricing pressure at the edges of your product.